Pharmacological inhibition of GSDMD with DMF in conjunction with anti-PD-L1 treatment markedly reduces tumor load and improves survival in melanoma mice.410 These studies provide new insights for combination therapy for cancers that, while anti-PD-1/anti-PD-L1 therapy is effective, numerous patients do not respond to this treatment. Here, CD274 is linked to melanoma.